
Commentary|Articles|March 12, 2015
The Incidence of Thyroid Cancer Among Breast Cancer Survivors
Author(s)Jennifer H. Kuo, MD
Jennifer H. Kuo, MD, director, Thyroid Biopsy Program, Columbia University, discusses a study looking at the incidence of thyroid cancer among breast cancer survivors.
Advertisement
Clinical Pearls
Jennifer H. Kuo, MD, director, Thyroid Biopsy Program, Columbia University, discusses a study looking at the incidence of thyroid cancer among breast cancer survivors.
- There is an increased risk for the development of thyroid cancer after having breast cancer. The highest risk is among younger patients.
- Adjuvant radiation therapy plays a role in this phenomenon.
- There were higher proportions of tall cell variant papillary, oxyphilic follicular, and anaplastic thyroid cancers observed after breast cancer in this study. These are more aggressive forms of disease compared with what is seen in the regular population.
Advertisement
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Approves Subcutaneous Amivantamab for EGFR-Mutated NSCLC Indications
2
Enfortumab Vedotin Plus Pembrolizumab Improves Survival in MIBC
3
FDA Grants Regular Approval to Rucaparib for BRCA-Mutated mCRPC
4
Long-Term ECHO Data Support Concurrent Acalabrutinib/BR in MCL
5








































